Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Frankfurt - Delayed Quote EUR

Qingling Motors Co., Ltd. (QIN.F)

Compare

0.0622

+0.0012

+(1.97%)

As of 8:13:15 AM GMT+1. Market Open.

Inflation in center focus amid tariff fears: What to know this week

Updates on inflation data for the month of February are set to greet investors as fears over the impact of President Trump's tariffs have recently sent the stock market into a slump.

Yahoo Finance 25 minutes ago

QQQ

^GSPC

^IXIC
Why Trump tariffs are burning up your portfolio

You have to think more critically about your investments right now than ever before!

Yahoo Finance 22 hours ago

HAS

WMT

M
BCA downgrades equities to underweight as US is heading towards recession

Investing.com -- BCA Research downgraded equities to underweight in a note Monday, warning that the U.S. economy is likely to slide into recession due to policy uncertainty and weakening consumer sentiment.

Investing.com 11 minutes ago

IVV

SPY

SPXL
AI Stocks: Tech Giants, Cloud Titans Face 'Show Me' Moment. Will Software Plays Take Over?

The good, bad and ugly for AI stocks: Meta shares have gained 7% in 2025. Google stock is down 8%. Nvidia stock has shed 16%.

Investor's Business Daily 18 minutes ago

ADBE

NVDA
Latest News In AI Chips - Leveraged ETFs Unlock Potent Trading Opportunities in Dynamic Markets

GraniteShares has launched two new leveraged exchange-traded funds (ETFs) focusing on AI chip technology, offering sophisticated investors amplified exposure to two prominent stocks: MARA Holdings and Marvell Technology. These ETFs, named GraniteShares 2x Long MARA Daily ETF (MRAL) and GraniteShares 2x Long MRVL Daily ETF (MVLL), aim to achieve 200% of the daily performance of MARA and MRVL, respectively, allowing for tactical trading based on market trends and news. The funds cater to...

Simply Wall St. 21 minutes ago

AMD

INTC

NVDA
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Monday; Intuitive Machines, Robinhood Markets to Decline

The most-talked-about stocks in the Reddit subforum Wallstreetbets were mostly lower hours before Mo

PREMIUM
MT Newswires 39 minutes ago

HOOD

AMD
Top India Drugmaker to Buy US-Based Checkpoint for $355 Million

(Bloomberg) -- Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.Most Read from BloombergNJ College to Merge With State School After Financial StressTrump Administration Plans to Eliminate Dozens of Housing OfficesWhere New York City's Zoning Reform Will Add HousingBuffalo’s Billion-Dollar Freeway Fix Is on Ice, But Not Because of TrumpInside the ‘Not Architecture’ of High Line Designers Diller Scofidio + Re

Bloomberg 42 minutes ago

CKPT

SUNPHARMA.NS
Rivian Is Living Up to Its Promises. Is This Top EV Stock Worth the Risk?

Rivian Automotive (NASDAQ: RIVN) is no Tesla, at least not yet, anyway. Tesla, right or wrong, is the target that most investors have in mind when they look at an electric vehicle (EV) maker. This company is living up to the promises it has made to investors but still has a long road ahead before it is a sustainably profitable company.

Motley Fool 43 minutes ago

RIVN

TSLA
Futures lower as tariff worries continue; Tesla falls

Tesla fell 2.6% after brokerage UBS lowered its forecast for the automaker's first-quarter deliveries and cut its price target on the stock. In an interview on Sunday, President Donald Trump declined to predict whether the U.S. could face a recession, at a time when investors are concerned that his fluctuating trade policies on Mexico, Canada and China could dampen consumer demand and corporate investment. China's retaliatory tariffs on some U.S. imports will take effect on Monday and U.S. tariffs on some base metals are expected to take effect later in the week.

Reuters 47 minutes ago

TSLA

^GSPC

^RUT
DoorDash, TKO, Williams-Sonoma To Join S&P 500. AppLovin Snubbed Again.

DoorDash, Williams-Sonoma, TKO and Expand Energy will join the S&P 500 index, while AppLovin was snubbed again.

Investor's Business Daily 53 minutes ago

TKO

EE

DASH
Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial

Bagsværd, Denmark, 10 March 2025 – Today, Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating once-weekly subcutaneous CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to placebo. The trial included 1,206 randomised people with obesity or overweight and type 2 diabetes and a mean baseline body weight of 102 kg. The trial achieved its pr

GlobeNewswire 1 hour ago

NONOF

NVO
Tesla’s stock defied gravity for years. Is Elon Musk’s EV party over?

Tesla’s stock has dropped by nearly half in three months. The company's market capitalization has dropped 45% since hitting an all-time high of $1.5 trillion on December 17, erasing most of the gains the stock made after CEO Musk helped finance the election victory of U.S. President Donald Trump. And yet Tesla continues to fetch a valuation far above those of the world’s biggest automotive and technology firms, judging by standard financial metrics.

Reuters 1 hour ago

TSLA
Beam Therapeutics Announces Pricing of Underwritten Offering

CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of an underwritten offering of 16,151,686 shares of its common stock at an offering price of $28.48 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,404,988 shares of common stock at an offering price of $28.47 per pre-funded warrant, before deduct

GlobeNewswire 1 hour ago

BEAM
Elon Musk's feud with OpenAI CEO Sam Altman, explained

Elon Musk's legal dispute against OpenAI could affect the future of one of the most prominent leaders in artificial intelligence.

LA Times 1 hour ago

TSLA
Beam Therapeutics Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (AATD), Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation

Single Dose of BEAM-302 Led to Durable, Dose-dependent Increases in Total and Functional Alpha-1 Antitrypsin (AAT), Production of Corrected M-AAT, and Decreases in Mutant Z-AAT in Circulation Across Initial Three Dose Levels Third Dose Level of BEAM-302 (60 mg, N=3) Achieved Mean Total AAT of 12.4µM at Day 28, Exceeding Protective Therapeutic Threshold, and Reduced Mutant Z-AAT up to 78% Initial Safety Findings Demonstrated BEAM-302 was Well Tolerated at All Dose Levels with No Serious Adverse E

GlobeNewswire 1 hour ago

BEAM
Tesla Stock Falls Again. Why Musk DOGE Fears May Continue to Eclipse AI Hope.

Searches for “DOGE” recently eclipsed search for “Tesla” on Google. That probably doesn’t make investors happy.

Barrons.com 1 hour ago

TSLA
Sun Pharma to acquire Checkpoint Therapeutics

Stockholders of Checkpoint are set to obtain an upfront cash payment of $4.10 per share of common stock.

Pharmaceutical Technology 1 hour ago

CKPT

SUNPHARMA.NS
These Stocks Are Moving the Most Today: DoorDash, Nvidia, Tesla, MicroStrategy, Cognizant, Oracle, and More

DoorDash rises on its addition to the S&P 500, Nvidia and Tesla shares trade lower, and crypto-linked stocks such as MicroStrategy fall on continued disappointment over how a strategic Bitcoin reserve is being capitalized.

Barrons.com 2 hours ago

NVDA

ORCL

MSTR
3 Mistakes to Avoid if the Stock Market Crashes in 2025

In the two-year period between 2023 and the end of last year, the S&P 500 (SNPINDEX: ^GSPC) rocketed 53.2% higher while the Nasdaq Composite (NASDAQINDEX: ^IXIC) surged a mind-numbing 84.5%. Both indexes are in the red year to date, with the Nasdaq down over 9% from its 52-week high. The sell-off is still a long ways away from a full-blown market crash, which is defined as a rapid decline of 20% or more.

Motley Fool 2 hours ago

COMP

NVDA
Will private equity kill Walgreens?

There are plenty of reasons to be skeptical that private equity will help Walgreens get out of turbulent times.

CNN Business 2 hours ago

WBA

AMZN

Performance Overview

Return	QIN.F	HANG SENG INDEX
YTD	+0.32%	+18.56%
1-Year	-14.56%	+45.43%
3-Year	+35.47%	+13.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Qingling Motors Co., Ltd. (QIN.F)

Related News

Inflation in center focus amid tariff fears: What to know this week

Why Trump tariffs are burning up your portfolio

BCA downgrades equities to underweight as US is heading towards recession

AI Stocks: Tech Giants, Cloud Titans Face 'Show Me' Moment. Will Software Plays Take Over?

Latest News In AI Chips - Leveraged ETFs Unlock Potent Trading Opportunities in Dynamic Markets

Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Monday; Intuitive Machines, Robinhood Markets to Decline

Top India Drugmaker to Buy US-Based Checkpoint for $355 Million

Rivian Is Living Up to Its Promises. Is This Top EV Stock Worth the Risk?

Futures lower as tariff worries continue; Tesla falls

DoorDash, TKO, Williams-Sonoma To Join S&P 500. AppLovin Snubbed Again.

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial

Tesla’s stock defied gravity for years. Is Elon Musk’s EV party over?

Beam Therapeutics Announces Pricing of Underwritten Offering

Elon Musk's feud with OpenAI CEO Sam Altman, explained

Beam Therapeutics Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (AATD), Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation

Tesla Stock Falls Again. Why Musk DOGE Fears May Continue to Eclipse AI Hope.

Sun Pharma to acquire Checkpoint Therapeutics

These Stocks Are Moving the Most Today: DoorDash, Nvidia, Tesla, MicroStrategy, Cognizant, Oracle, and More

3 Mistakes to Avoid if the Stock Market Crashes in 2025

Will private equity kill Walgreens?

Performance Overview